Literature DB >> 22918729

Platelets in atherosclerosis and thrombosis.

Christian Schulz1, Steffen Massberg.   

Abstract

Rupture of an atherosclerotic plaque exposes a thrombogenic matrix, which instantly triggers platelet tethering and activation. We here delineate the sequence of events during arterial thrombus formation and dissect the specific role of the various platelet receptors in this process. We also discuss the interplay of platelets with circulating immune cells, which support arterial thrombosis by fibrin formation in a process that involves extracellular nucleosomes. In the second part of this chapter we describe the role of platelets in atherosclerotic lesion formation. Platelets adhere to the dysfunctional endothelium early during atherogenesis. They contain a large machinery of proinflammatory molecules, which can be released upon their activation. This prepares the ground for subsequent leukocyte recruitment and infiltration, and boosts the inflammatory process of the arterial wall. Together, platelets play a critical role in both acute and chronic processes of the vascular wall, which makes them an attractive target for pharmacological strategies to treat arterial thrombosis and, potentially, also atheroprogression.

Entities:  

Mesh:

Year:  2012        PMID: 22918729     DOI: 10.1007/978-3-642-29423-5_5

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  15 in total

Review 1.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 2.  Platelet Signaling Pathways and New Inhibitors.

Authors:  Steven P Grover; Wolfgang Bergmeier; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04       Impact factor: 8.311

Review 3.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Platelet function testing in patients with acute coronary syndrome.

Authors:  Martin Orban; Dirk Sibbing
Journal:  J Cardiovasc Transl Res       Date:  2013-02-09       Impact factor: 4.132

5.  Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and myocardial infarction risk.

Authors:  Meng Fan; Sonny Dandona; Ruth McPherson; Hooman Allayee; Stanley L Hazen; George A Wells; Robert Roberts; Alexandre F R Stewart
Journal:  Circ Cardiovasc Genet       Date:  2013-05-31

Review 6.  Dual pathway therapy in acute coronary syndrome.

Authors:  Peter Stachon; Ingo Ahrens; Christoph Bode; Andreas Zirlik
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

7.  Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation.

Authors:  Julia Novotny; Sue Chandraratne; Tobias Weinberger; Vanessa Philippi; Konstantin Stark; Andreas Ehrlich; Joachim Pircher; Ildiko Konrad; Paul Oberdieck; Anna Titova; Qendresa Hoti; Irene Schubert; Kyle R Legate; Nicole Urtz; Michael Lorenz; Jaroslav Pelisek; Steffen Massberg; Marie-Luise von Brühl; Christian Schulz
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 8.  New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.

Authors:  Meng-Yu Wu; Chia-Jung Li; Ming-Feng Hou; Pei-Yi Chu
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

9.  Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets.

Authors:  Mao Luo; Rong Li; Meiping Ren; Ni Chen; Xin Deng; Xiaoyong Tan; Yongjie Li; Min Zeng; Yan Yang; Qin Wan; Jianbo Wu
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

Review 10.  Non-genomic effects of nuclear receptors: insights from the anucleate platelet.

Authors:  Amanda J Unsworth; Gagan D Flora; Jonathan M Gibbins
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.